deltatrials
Completed OBSERVATIONAL NCT05483036

Perception in Parkinson's Disease

Sponsor: Boston University Charles River Campus

Conditions Parkinson's Disease Perception Visual Hallucination
Updated 6 times since 2022 Last updated: Sep 15, 2025 Started: Sep 1, 2022 Primary completion: May 1, 2025 Completion: May 1, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05483036, this observational or N/A phase trial focuses on Parkinson's Disease and Perception and remains completed. Sponsored by Boston University Charles River Campus, it has been updated 6 times since 2022, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Sep 2022 – ~Apr 2023 · 7 months · monthly snapshotRecruiting~Apr 2023 – ~Jun 2023 · 2 months · monthly snapshot~Jun 2023 – ~Jul 2024 · 13 months · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Oct 2025 · 13 months · monthly snapshotRecruiting~Oct 2025 – present · 11 months · monthly snapshotCompleted

Change History

6 versions recorded

  1. Oct 2025 — Present [monthly]

    Completed

    Status: Recruiting → Completed

  2. Sep 2024 — Oct 2025 [monthly]

    Recruiting

  3. Jul 2024 — Sep 2024 [monthly]

    Recruiting

  4. Jun 2023 — Jul 2024 [monthly]

    Recruiting

  5. Apr 2023 — Jun 2023 [monthly]

    Recruiting

▶ Show 1 earlier version

  1. Sep 2022 — Apr 2023 [monthly]

    Recruiting

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Boston University Charles River Campus
Data source: Boston University Charles River Campus

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations